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Abstract
Molecular underpinnings of complex psychiatric disorders such as autism spectrum disorders (ASD) remain largely
unresolved. Increasingly, structural variations in discrete chromosomal loci are implicated in ASD, expanding the search
space for its disease etiology. We exploited the high genetic heterogeneity of ASD to derive a predictive map of candidate
genes by an integrated bioinformatics approach. Using a reference set of 84 Rare and Syndromic candidate ASD genes
(AutRef84), we built a composite reference profile based on both functional and expression analyses. First, we created a
functional profile of AutRef84 by performing Gene Ontology (GO) enrichment analysis which encompassed three main
areas: 1) neurogenesis/projection, 2) cell adhesion, and 3) ion channel activity. Second, we constructed an expression profile
of AutRef84 by conducting DAVID analysis which found enrichment in brain regions critical for sensory information
processing (olfactory bulb, occipital lobe), executive function (prefrontal cortex), and hormone secretion (pituitary). Disease
specificity of this dual AutRef84 profile was demonstrated by comparative analysis with control, diabetes, and non-specific
gene sets. We then screened the human genome with the dual AutRef84 profile to derive a set of 460 potential ASD
candidate genes. Importantly, the power of our predictive gene map was demonstrated by capturing 18 existing ASD-
associated genes which were not part of the AutRef84 input dataset. The remaining 442 genes are entirely novel putative
ASD risk genes. Together, we used a composite ASD reference profile to generate a predictive map of novel ASD candidate
genes which should be prioritized for future research.
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Introduction
Autism (MIM 209850) is a broad-spectrum multi-factorial
condition which onsets in the first years of life and persists
throughout the lifetime [1]. A triad of deficits in the areas of social
communication, language development, and repetitive activities/
restricted range of interests defines the core symptoms used in the
diagnosis of autism (DSM IV, 1994). The affected areas show a
broad range of variability in terms of both symptoms and severity;
co-morbidity of epilepsy and mental retardation are often
observed. Autism spectrum disorders (ASD) is a commonly used
term to cover the wide variations of autism. The dramatic rise in
the prevalence of ASD in recent years is of major public concern
[2–3].
A strong genetic component underlying ASD has been firmly
established from various lines of studies [4–7]. The search for
‘causative’ gene(s) has resulted in .10 whole genome scans
reporting numerous putative linkage regions for ASD suscep-
tibility [8–9]. Genetic association studies have identified
numerous candidate genes for ASD [10–12]; however, most
candidates fail to replicate between studies and populations. In
a minor proportion of cases, chromosomal aberrations have
been identified [13]. Recently, submicroscopic copy number
variations (CNVs) were strongly associated with ASD [8,14–
15]. Additionally, ASD is consistently associated with a number
of specific genetic disorders such as Fragile X Syndrome [16–
17]. Single gene mutations are also linked to rare cases of ASD
[18–19].
Together, hundreds of diverse genetic loci gathered from high
throughput studies have been implicated in this disorder.
Addressing the complexity of ASD, we have developed AutDB
[20–21], a publicly available web-portal for on-going collection,
manual curation, and visualization of genes linked to the
disorder. First released by our laboratory in 2007, AutDB is
widely used by both individual laboratories [22–25] and
consortiums (Simons Foundation) [26] for understanding genetic
bases of ASD.
Functional studies for isolated candidate genes have provided
important insight into ASD but are largely restricted to rare
monogenic forms of the disorder [27–28]. Here, we have
exploited the genetic heterogeneity of ASD to create a predictive
gene map for novel ASD candidate genes. To build this
predictive map, we assembled a reference dataset of 84 ASD
candidate genes from AutDB for dual profiling with both
functional and expression analysis. We then used this dual profile
to construct a predictive gene map for ASD which can be utilized
in future research regarding pathogenesis of this complex
psychiatric disorder.
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AutRef84 as an ASD Gene Reference Dataset
A reference dataset of ASD candidate genes was initially
extracted from the autism gene database AutDB [20–21]. This
resource provides systematic collection of candidate genes linked
to ASD encompassing four genetic classifications 1) Rare: rare
single gene variants, disruptions/mutations, and submicroscopic
deletions/duplications directly linked to ASD, 2) Syndromic: genes
implicated in syndromes in which a significant subpopulation
develops autistic symptoms, 3) Association: small risk-conferring
candidate genes with common polymorphisms identified from
genetic association studies in idiopathic ASD, and 4) Functional:
functional candidates. Genes belonging to more than one category
are classified with both names.
In order to generate a high-confidence predictive gene map for
ASD, we restricted the ASD reference gene set to higher risk-
conferring, more penetrant ASD candidate genes. We filtered out
lower risk-conferring ASD candidate genes, including Functional
candidates devoid of any experimentally determined genetic link
with ASD, as well as Association genes, which have suggestive
evidence linking them to ASD [25,29–30]. For instance, none of
Figure 1. Integrated analysis of reference sets of genes Linked to ASD. A reference dataset of ASD-linked genes (AutRef84) was assembled
from the Rare and Syndromic categories of AutDB (http://www.mindspec.org/autdb.html), a publicly available portal for ongoing collection of genes
linked to ASD. A) Distribution of genetic categories in AutDB. B) Reference sets were analyzed using structured biological knowledge provided by
Gene Ontology (GO) consortium [31].
doi:10.1371/journal.pone.0028431.g001
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have reached genome-wide GWAS with independent replication
or meta-analysis. The vast majority of candidate genes identified
from genetic association studies are unreplicated or underpow-
ered.
The resulting ASD reference gene set, AutRef84, included 64
Rare and 20 Syndromic genes (Figure 1A), the total number of genes
identified within these categories as of the data-freeze. The list of
AutRef84 genes is presented in Table 1, whereas a more
annotated version is provided as Table S1. The AutRef84 dataset
encompasses well-studied candidates such as neuroligins (NLGN1,
NLGN3, and NLGN4X), MECP2, FMR1, and TSC1/2, together
with lesser-known genes with single reports including RPL10,
CACNA1C, and DPP6. Hence, AutRef84 captures the broad
landscape of ASD-linked genes suitable for applying statistical
analysis to derive common gene functions.
We then applied AutRef84 to generate a predictive gene map
for ASD, as depicted by the schematic of our workflow presented
in Figure 1B. In brief, we first performed a dual profile of
AutRef84 consisting of both functional and expression analyses.
We then screened the human genome with both branches of this
profile in order to identify putative novel ASD candidate genes, as
described below.
Functional Profile: Common Biological Functions in
AutRef84
To ascertain common biological functions associated with ASD-
related genes, we adopted an integrated bioinformatics approach
based on structured biological knowledge provided by Gene
Ontology (GO) consortium [31]. We applied GO enrichment
analysis to the AutRef84 dataset based on conditional Hypergeo-
metric calculation of over-represented GO terms using Biocon-
ductor packages [32]. Briefly, all three branches of GO knowledge
structure (biological process (BP), molecular function (MF), and
cellular component (CC)) were utilized for this analysis. To test for
GO category enrichment, we performed the conditional Hyper-
geometric function of Bioconductor using a set of stringent filter
criteria: 1) P-value cutoff of 0.001, 2) limited GO annotation
category size of 100#x#1000 to minimize artificial elevation of P-
value, and 3) gene count of .4 in significant categories. Applying
these filters, a total of 15 enriched GO categories were identified in
AutRef84: 10 BP categories, three MF categories, and two CC
categories (Table 2). Examples of enriched categories with highest
gene content per GO branch include cell adhesion (BP: 13 genes;
P=1.1610
24), cation transport (BP: 10 genes, P=7.9610
24),
neurogenesis (BP: 10 genes, P=4.0610
25), voltage-gated channel activity
(MF: 6 genes; P=3.4610
24), and synapse (CC; 7 genes;
P=6.2610
24).
For additional support, we also performed GO enrichment
analysis using the DAVID bioinformatics resource, which employs
a Fisher’s Exact Test instead of a conditional Hypergeometric test.
With a P-value cut-off of p,0.05, we derived a total of 26 enriched
GO categories using DAVID analysis: 21 BP categories and five
CC categories (Table S2). Whereas all categories from both
analyses related to similar themes, the two CC categories derived
from Bioconductor matched exactly with those generated from
DAVID, as did four of the BP categories.
We further characterized functionality of the AutRef84 gene set
by conducting pathway analysis with Pathway Express [33]. Using
the KEGG database, we derived five significantly enriched
molecular pathways: cell adhesion molecules (6 genes, P=7.5
610
26), mTOR signaling pathway (4 genes, P=3.3610
25), calcium
signaling pathway (5 genes, P=4.4610
24), p53 signaling pathway (3
genes, P=1.8610
23), and MAPK signaling pathway (5 genes,
P=2.6610
23)( Table S3). One of these pathways, cell adhesion
molecules, is shared exactly with the GO enrichment analysis. The
other categories are shared indirectly: calcium signaling pathway is
included in the GO enrichment categories cation transport and cation
channel activity, while the mTOR, p53, and MAPK signaling pathways
relate to the GO enrichment category negative regulation of signaling
transduction.
To visualize the relationship among enriched GO categories, we
generated directed acyclic graphs based on GO knowledge
structure. The terminal nodes of these GO Trees, devoid of any
ascendants provide a framework for semantics of candidate gene
functions in AutRef84. Within the BP graph (Figure 2), enriched
terminal nodes relate to ion channel activity (sodium ion transport:5
genes, P=6.9610
24; negative regulation of signal transduction: 6 genes,
P=3.3610
24; regulation of system process: 6 genes, P=6.0610
24;
regulation of phosphate metabolic process: 8 genes, P=9.7610
24),
neurogenesis/projection (neuron projection development: 6 genes,
P=4.8610
24), or cell adhesion (cell adhesion: 11 genes;
P=8.4610
24). Notably, the largest structural component of the
BP GO Tree is connected to neuron projection development, which
includes the enriched GO categories of neuron differentiation (9 genes,
P=6.0610
25), neurogenesis (10 genes, 4.0610
25), and central nervous
system development (9 genes, P=4.0610
25). Within the AutRef84
MF graph (Figure S1), enriched terminal nodes also relate to ion
channel activity (voltage-gated cation channel activity: 6 genes,
Table 1. AutRef84: A Reference set of Rare and Syndromic ASD-linked genes.
Rare Syndromic
ANKRD11 CNTN4 FHIT MBD4 PARK2 RFWD2 ST7 AHI1 DMD
AGAP1 CNTNAP2 GALNT13 MCPH1 PCDH10 RIMS3 SUCLG2 DHCR7 FMR1
APC DLGAP2 GRPR MDGA2 PCDH9 RPL10 TMEM195 DMPK MECP2
ASTN2 DPP10 IL1RAPL1 NBEA PLN RPS6KA2 UBE3A ADSL NF1
AUTS2 DPP6 IMMP2L NLGN1 PTCHD1 SCN1A AGTR2 NTNG1
BZRAP1 DPYD JMJD1C NLGN3 RAB39B SCN2A ALDH5A1 PTEN
C3orf58 EIF4E KCNMA1 NLGN4X RAPGEF4 SEZ6L2 ARX SLC6A8
CA6 FABP5 KIAA1586 NRXN1 RB1CC1 SHANK3 CACNA1C TSC1
CACNA1H FABP7 MBD1 ODF3L2 RBFOX1 SLC4A10 CACNA1F TSC2
CADM1 FBXO40 MBD3 OR1C1 REEP3 SLC9A9 CDKL5 XPC
doi:10.1371/journal.pone.0028431.t001
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1
GO ID GO Term P- Value Odds Ratio Exp Count AutRef84 Genes Size
ASD BP GO:0007417 Central Nervous
System Development
4.00E-05 6.235 1.656 9 303
GO:0022008 Neurogenesis 4.00E-05 5.485 2.104 10 385
GO:0030182 Neuron Differentiation 6.00E-05 5.847 1.760 9 322
GO:0007155 Cell Adhesion 1.10E-04 3.907 3.902 13 714
GO:0009968 Negative Regulation
of Signal Transduction
3.30E-04 7.180 0.929 6 170
GO:0031175 Neuron Projection
Development
4.80E-04 6.646 1.000 6 183
GO:0044057 Regulation of System Process 6.00E-04 6.355 1.044 6 191
GO:0019220 Regulation of Phosphate
Metabolic Process
9.70E-04 4.344 2.049 8 375
GO:0006814 Sodium Ion Transport 6.90E-04 7.818 0.705 5 129
GO:0006812 Cation Transport 7.90E-04 3.740 3.012 10 536
MF GO:0022843 Voltage-Gated Cation
Channel Activity
7.00E-05 9.662 0.699 6 135
GO:0031402 Sodium Ion Binding 2.60E-04 9.760 0.570 5 110
GO:0022832 Voltage-Gated
Channel Activity
3.40E-04 7.098 0.938 6 181
CC GO:0034703 Cation Channel Complex 6.00E-05 9.980 0.675 6 125
GO:0045202 Synapse 6.20E-04 5.309 1.454 7 269
Diabetes BP GO:0065008 Regulation of
Biological Quality
2.49E-09 9.553 2.772 16 948
GO:0003013 Circulatory System Process 2.67E-09 17.334 0.747 10 194
GO:0009893 Positive Regulation
of Metabolic Process
6.80E-08 7.801 2.450 14 662
GO:0016265 Death 8.95E-04 3.552 3.706 11 963
GO:0012501 Programmed Cell Death 1.55E-03 3.503 3.356 10 872
MF GO:0005179 Hormone Activity 6.26E-03 8.644 0.376 3 101
GO:0019900 Kinase Binding 9.82E-03 7.293 0.443 3 119
CC GO:0000267 Cell Fraction 2.00E-03 3.608 2.881 9 805
GO:0031090 Organelle Membrane 4.62E-03 3.419 2.671 8 787
Control* BP GO:0032940 Secretion By Cell 2.36E-05 4.921 2.856 12 524
GO:0010647 Positive Regulation Of
Cell Communication
4.50E-05 4.964 2.570 11 478
GO:0023056 Positive Regulation
Of Signaling
4.76E-05 4.931 2.586 11 481
GO:0010740 Positive Regulation Of
Intracellular Protein
Kinase Cascade
6.29E-05 6.644 1.365 8 254
GO:0018130 Heterocycle Biosynthetic
Process
8.27E-06 6.727 1.741 10 343
GO:0034654 Nucleobase, Nucleoside,
Nucleotide And Nucleic
Acid Biosynthetic Process
1.84E-05 6.881 1.513 9 298
GO:0044283 Small Molecule
Biosynthetic Process
6.05E-05 4.467 3.158 12 622
GO:0009165 Nucleotide Biosynthetic
Process
7.63E-05 6.472 1.406 8 277
GO:0051090 Regulation Of Transcription
Factor Activity
2.94E-05 7.432 1.226 8 225
GO:0051098 Regulation Of Binding 3.30E-05 6.341 1.624 9 298
GO:0043254 Regulation Of Protein
Complex Assembly
2.69E-05 11.554 0.591 6 110
GO:0031329 Regulation Of Cellular
Catabolic Process
7.47E-05 6.488 1.401 8 272
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25; sodium ion binding: 5 genes, P=2.6610
24). Similarly,
within the AutRef84 CC graph (Figure S2), enriched terminal
nodes describe cellular components important for ion channel
activity (cation channel complex: 6 genes, P=6.0610
25) or ion
channel activity/cell adhesion (synapse: 7 genes, P=6.2610
24).
Expression Profile: Region-Specific Enrichment of
AutRef84
We next performed tissue-specific expression analysis of
AutRef84 using the DAVID bioinformatics resource. We
discovered nine anatomical regions of highly enriched ASD
candidate gene expression (P#1.0610
24; accounting for multiple
testing), including four brain regions: 1) the olfactory bulb (33
genes, P=1.7610
28), which transmits smell; 2) the occipital lobe
(32 genes, P=1.0610
26), which processes visual information; 3)
the prefrontal cortex (25 genes, P=3.1610
24), which is important
for executive function; and 4) the pituitary (26 genes,
P=3.2610
24), which regulates hormone secretion (Figure 3).
The enrichment of ASD-linked genes within non-brain regions is
not surprising, given the pleiotropic expression of genes within the
human body. However, due to the categorization of ASD as a
neuropsychiatric illness, we focused exclusively on enriched brain
regions. A list of AutRef84 genes expressed within each region is
provided in Table S4.
We then performed network representation to illustrate
relationships of AutRef84 gene expression among these shared
brain regions (Figure 4). Of the AutRef84 gene set, a total of 45
genes were enriched among these four brain regions. A core set of
16 genes showed enriched expression in all four brain regions:
A2BP1, APC, CNTNAP2, DPP6, FABP7, IL1RAPL1, NBEA,
NF1, NLGN3, NLGN4X, NRXN1, PCDH9, RAPGEF4,
RIMS3, SCN2A, and SEZ6L2. Additionally, eight genes were
expressed in three regions (including the Rett Syndrome gene
MECP2 and the Fragile X Syndrome gene FMR1), ten genes were
expressed in two regions, and eight genes were expressed in only
one of these enriched regions.
Disease Specificity of AutRef84 Dual Profile
To examine disease specificity of the AutRef84 dual profile, we
compared it to both 1) a diabetes set of 54 genes serving as a
disease-specific control (Table S5), 2) a non-specific disease
reference set of 78 genes generated by randomly sampling genes
the OMIM database which did not show significant association to
any one particular disease, and 3) 1000 control gene sets of size
n=84 that were randomly sampled from the OMIM database.
First, we analyzed AutRef84 functional profile specificity. By
performing GO enrichment analysis with the same filtering criteria
as above, we found that the diabetes gene set was enriched within
nine GO categories (five BP categories, two MF categories, and
two CC categories) (Table 2), and the 1000 random control gene
sets were enriched within 18 GO categories (all BP categories)
(Table 2). None of the top enriched GO terms were shared
among ASD, diabetes, and control datasets. Whereas the top
enriched GO terms for ASD were concentrated in synaptic
functions, the diabetes reference set was enriched for metabolic
cellular processes, and the control reference sets were distributed
primarily across various signaling pathways.
Second, we examined AutRef84 expression profile specificity.
For this analysis, we used compared AutRef84 with the diabetes
gene set as well as a non-specific disease gene set assembled by
randomly sampling OMIM (Table S6). Region-specific enrich-
ment of the diabetes gene set was restricted to the pons, whereas
expression of the non-specific disease dataset was concentrated in
the uterus and three brain regions distinct from that of ASD
(Figure 3). Like the functional profile, no enrichment was shared
among ASD, diabetes, and non-specific disease datasets. Although
each gene set showed enrichment in distinct brain regions, it is
noteworthy that statistical significance of the enriched ASD brain
regions was generally two orders of magnitude higher than those of
diabetes and non-specific disease datasets. Eight of the nine ASD
regions satisfy a more stringent P-value of 0.001 (Figure 3, dotted
line), whereas none of the diabetes and control regions meet this
cut-off, implying that brain region enrichment of ASD genes is
much less likely to occur by chance.
Predictive Gene Map Generated with Dual AutRef84
Profile
The creation of AutRef84 provides a usable framework for
systems biology analysis of molecular events underlying ASD
pathogenesis. Here we applied the dual AutRef84 profile to
generate a predictive gene map for ASD. First we used the
functional AutRef84 profile to screen the human genomic
sequence at Ensembl database (NCBI build 36) with the biomaRt
package of Bioconductor. We identified 1185 genes matching the
functional AutRef84 profile (Table S7), and their genome-wide
distribution pattern is illustrated in Figure 5. This map indicates
GO ID GO Term P- Value Odds Ratio Exp Count AutRef84 Genes Size
GO:0009141 Nucleoside Triphosphate
Metabolic Process
8.57E-06 6.020 2.153 11 418
GO:0009205 Purine Ribonucleoside
Triphosphate Metabolic
Process
4.20E-05 5.505 2.102 10 408
GO:0009259 Ribonucleotide
Metabolic Process
8.22E-05 5.058 2.277 10 442
GO:0071844 Cellular Component
Assembly At Cellular Level
5.31E-05 4.004 4.165 14 797
GO:0051336 Regulation Of Hydrolase
Activity
6.90E-05 4.716 2.692 11 494
GO:0006259 DNA Metabolic Process 1.42E-05 4.856 3.199 13 621
BP=Biological Process, MF=Molecular Function, CC=Cellular Component.
*=1000 gene sets of n=84, randomly assembled from OMIM.
doi:10.1371/journal.pone.0028431.t002
Table 2. Cont.
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discrete chromosomal regions that reached statistical significance
using a DAVID analysis with a P-value cut-off value of p,0.05
(Table S8).
We then applied the AutRef84 expression profile to filter this
initial predictive gene set. Using network representation of shared
brain expression within the set of 1185 genes described above, we
defined a subset of 460 genes matching both functional and
expression profiles of AutRef84 (Figure 6). Of this subset, 159
genes are expressed in all four enriched brain regions, 62 genes
were common to three of the enriched brain regions, 89 genes
overlapped in two of the enriched regions, and 150 genes were
expressed in only one of the enriched brain regions (Table S9).
Importantly, the accuracy of the final predictive gene map was
demonstrated by correctly capturing 18 existing ASD-associated
genes which were not part of the AutRef84 input dataset (Table
S10): 13 genes linked to ASD by genetic association studies
(therefore part of the Association category of AutDB), three genes
whose function is relevant to ASD (therefore included in the
Functional category of AutDB), and two Rare/Syndromic genes that
have been discovered since the original AutRef84 data-freeze.
Some of these candidate genes are particularly interesting
candidates for ASD, such as GABRB3, a GABA receptor subunit
linked to ASD by multiple association studies [34–41], NPAS2, a
transcription factor involved in circadian rhythms that has been
associated with ASD [42]; RELN, an extracellular matrix protein
involved in cell migration whose association with ASD has been
replicated [43–46]; and SEMA5A, an axon guidance molecule
shown to be downregulated in ASD [47]. However, the remaining
442 genes have not previously been associated with ASD and form
a novel pool of potential ASD candidate genes.
Discussion
In this report, we have defined the first composite reference
profile of ASD candidate genes, AutRef84. In contrast to another
Figure 2. AutRef84 functional profile: graphical representation of over-represented Biological Process (BP) categories. Using
Bioconductor, we generated directed acyclic graphs based on GO knowledge structure. Enriched GO categories of AutRef84 are represented by
rectangular boxes. Terminal nodes are illustrated in yellow. The largest structural component of the BP GO Tree is connected to neuron projection
development, which includes the enriched GO categories of neuron differentiation (9 genes, P=6.0610
25), neurogenesis (10 genes, 4.0610
25), and
central nervous system development (9 genes, P=4.0610
25). Other enriched terminal nodes relate to ion channel activity or cell adhesion.
doi:10.1371/journal.pone.0028431.g002
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genes [48], here we created a dual reference profile of AutRef84
by performing both functional and expression analyses of ASD
candidate genes. Derived from data extracted from .158
references, AutRef84 consolidates knowledge about Rare and
Syndromic ASD genes, whose relationship to ASD has been firmly
established. For the functional profile, we conducted GO
enrichment to discover that AutRef84 genes are enriched in
biological functions related to three major areas: 1) neurogenesis/
projection, 2) cell adhesion, and 3) ion channel activity. For the
expression profile, we analyzed tissue-specific expression patterns
to find that AutRef84 genes are enriched in brain regions vital to
sensory information processing (olfactory bulb, occipital lobe),
executive function (prefrontal cortex), and hormone secretion
(pituitary). We then applied this dual profile to create a genome-
wide predictive gene map for ASD consisting of 460 putative
candidate genes. Of these 460 genes, 18 were previously associated
with ASD but were included in our input AutRef84 dataset,
demonstrating the predictive power of this gene map. The
remaining 442 genes are entirely novel putative ASD risk genes.
Together, our predictive gene map can serve as a tool for
researchers to prioritize molecular pathways underlying ASD
pathogenesis, thereby accelerating the discovery of targeted
treatments for this disorder.
Our functional profile revealed that ASD candidate genes are
concentrated in three biological processes critical for synaptic
transmission: neurogenesis/projection, cell adhesion, and ion
channel activity. A ‘synaptic dysfunction’ hypothesis for ASD is
widely acknowledged [49–50]. However, molecular support for
this hypothesis rests mainly on cell adhesion binding partners
neuroligins (NLGN3, NLGN4X) and neurexins (NRXN1), as well
as the scaffolding protein SHANK3 – all identified in rare cases of
ASD. The availability of curated, annotated datasets of ASD-
linked genes provides unique computational opportunities to
identify common biological functions associated with these genes
[25]. Here, we use a reference set of genes, rigorous statistical
analysis, and comparative analysis with multiple control datasets to
provide molecular support for synaptic bases of ASD.
For instance, the largest concentration of synaptic categories for
ASD-linked genes involves ion regulation. Six of the 15 enriched
GO categories for AutRef84 were sodium transport, cation transport,
voltage-gated cation channel, sodium ion binding, voltage-gated channel
activity, and cation channel complex. This unbiased study of ASD
candidate genes supports a previously established theory of ASD
pathogenesis proposing an increased excitation:inhibition ratio
[51]. In correspondence with this theory, approximately 10–30%
of individuals with autism are also diagnosed with epilepsy [52–
53], a disease caused by ion channel dysfunction. To further
examine the role of ion channels in both diseases, future studies
should compare the functional profile of AutRef84 with one
created from an epilepsy reference gene set.
Another major component of our ASD reference profile is
neurogenesis/projection. Enriched GO categories within this
neurobiological classification included neurogenesis, neuron differenti-
ation, neuron projection development, central nervous system development, and
cell adhesion. Impairments of these neurodevelopmental processes
may contribute to accelerated head growth observed in children
with ASD [54–55]. Additionally, neurogenesis continues to play a
role in adult function of brain regions such as the hippocampus
[56] and amygdala [57]. Inability of neurons to regenerate within
Figure 3. AutRef84 expression profile: region-specific enrichment of gene expression. Analysis of tissue expression profiles for AutRef84
genes using the DAVID bioinformatics tool (http://david.abcc.ncifcrf.gov/) demonstrates region-specific enrichment with high statistical significance
(p,0.0001) in four areas of the central nervous system: olfactory bulb, occipital lobe, prefrontal cortex, and pituitary. Whereas the olfactory bulb and
occipital lobe are involved in sensory processing (smell and vision, respectively), the prefrontal cortex controls executive function and the pituitary
gland directs hormone secretion. None of the enriched regions overlapped with those of diabetes or non-specific disease gene sets. *=Bonferroni
corrected.
doi:10.1371/journal.pone.0028431.g003
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observed in autism [58–59].
Our expression profile defines four critical brain regions of ASD
pathogenesis: olfactory bulb, occipital lobe, prefrontal cortex, and
pituitary. Dysfunction of each of these brain areas in ASD has
been suggested by previous functional evidence. For example, he
olfactory bulb, which transmits information pertaining to smell,
has been strongly implicated in mouse models of ASD due to its
well-established role in their social behavior [60]. Interestingly,
humans with ASD also exhibit altered olfactory perception [61–
62]. Electrical abnormalities have been observed in the occipital
lobe of ASD individuals [63], suggesting that impaired facial
recognition associated with ASD [64] may at least partially be due
to altered visual processing. The prefrontal cortex is critical for
executive function skills deficient in ASD, such as decision-making,
attention, and working memory. In support, ASD individuals
exhibit decreased activation of the prefrontal cortex when
performing cognitive tasks [65]. Finally, impaired hormone
secretion by the pituitary has long been proposed to contribute
to ASD [66], although recent studies have highlighted the
potential importance of hormones underlying social behavior,
such as oxytocin and vasopressin [67].
Although our AutRef84 expression profile highlights anatomical
regions likely to be involved in ASD pathogenesis, it should be
interpreted with caution. The four brain regions described above
(olfactory bulb, occipital lobe, prefrontal cortex, and pituitary) are
the only ones which survived multiple testing in our statistical
analysis, but previous evidence suggests that other brain regions
functionally relevant to ASD such as the amygdala or cerebellum
may also be involved [58,68]. Likewise, some AutRef84 genes
were enriched in non-brain regions, reflecting the pleiotropic
expression of genes within the human body. Notably, although
expression profiles of diabetes and control datasets also showed
enrichment in some brain regions, these brain regions were
distinct from of ASD genes and, more importantly were two orders
of magnitude less statistically significant. Together, disease
specificity of the AutRef84 dual profile indicates the utility of
disease-based reference profiling.
Notably, the results of our computational analysis match
evidence generated by single gene studies. For example, our
expression profile identified the cell adhesion molecule CNTNAP2
as one of the core set of 16 AutRef84 genes enriched in all four
significant brain regions, prioritizing it as a high-confidence ASD
candidate gene. In support, one recent neuroimaging study used
magnetic resonance imaging (MRI) and diffusion tensor imaging
to demonstrate that subjects with an ASD-associated single
nucleotide polymorphism in CNTNAP2 showed a significant
reduction in grey and white matter volume of the occipital and
frontal lobes compared with controls [69]. Likewise, a newly
published functional MRI showed that another ASD-associated
single nucleotide polymorphism of CNTNAP2 altered functional
connectivity within the frontal lobe [70]. Additional functional
studies will be critical for defining the contribution of our
prioritized gene set to molecular pathways dysfunctional in ASD.
In conclusion, our predictive gene map for ASD is a valuable
tool by which to prioritize the field of ASD genomics. Our
composite reference profile of AutRef84 also provides insight into
the molecular etiology of autism, with important implications for
drug development. Moreover, our construction and evaluation of
AutRef84 can act as a general model for consolidating collective
knowledge of a complex disorder into a usable framework of
common biological functions.
Figure 4. Network analysis of the AutRef84 expression profile. In this visual representation of the network, each group of gene nodes is
spatially positioned near the brain region or regions in which the genes are expressed. The color of each group of gene nodes was derived by
averaging red, green, and blue values of the colors of the linked brain region nodes.
doi:10.1371/journal.pone.0028431.g004
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Compilation of Gene ASD and Control Reference Sets
We have developed an autism gene database, AutDB [71,20–
21]), for ongoing cataloguing of genes linked to ASD. A
comprehensive collection of ASD-linked genes was initially
compiled from an exhaustive search of the scientific literature
from PubMed database at NCBI [72]. The search terms included
‘gene’ AND (‘autism’ OR ‘autistic’) restricted to the titles and
abstracts of the publication for retrieval. Furthermore, candidate
genes listed in review articles on molecular genetics of ASD, along
with cross-references therein, were mapped and added (if new) to
our candidate gene list from PubMed searches to compile the most
exhaustive gene set. After its first release (Jan 1, 2007), a daily
semi-automated search of PubMed with the same keywords was
performed to maintain an up-to-date resource of all candidate
genes linked to ASD. Additionally, relevant journal articles in the
fields of genetics, neurobiology, and psychiatry were screened on a
regular basis to enrich the resource. AutRef84 assembled with a
data-freeze of May 2010. The authors individually verified all
candidate genes included in the reference dataset by reading the
full-text primary reference article linking the candidate gene to
ASD.
Non-ASD gene sets were compiled using the Online Mendelian
Inheritance in Man (OMIM) database [73]. The diabetes dataset
consisted of 54 genes verified for linkage association with diabetes
and expression in Beta Cells/Islets in the Type 1 Diabetes
Database [74] and manually analyzed to exclude any genes whose
link to Diabetes was based on genetic association studies.
The non-specific disease reference set was curated by generating
a random sampling of 78 genes from the OMIM database which
did not show significant association to any one particular disease.
The 1000 control gene sets of n=84 were assembled by randomly
sampling the OMIM database.
Bioconductor Analysis
Enrichment of GO categories was performed using the Condi-
tional HyperGTest in the annotation background of hgu133a as
described in the GOStats vignette (S.Falcon and R. Gentlemen,
October 3, 2007).The Conditional HyperG Testuses the structure of
the GO graph to estimate for each term whether or not there is
evidence beyond that which is provided by the term’s children to
designate the term statistically over-represented. The algorithm
conditions on all child terms also significant at the specified P-value
cut-off. Given a subgraph of one of the three GO ontologies, the
terms with no child categories are tested first, followed by the nodes
whose children have already been tested. If any of a given node’s
children tested significant, the appropriate conditioning is performed.
Results of the Conditional HyperG Test were analyzed and
visualized in an Excel spreadsheet for GO category, P-value, Odds
ratio, Expected count, AutRef84 gene count, and annotation
category size (Table S2). The hierarchical relationship between
enriched GO terms was visualized by constructing directed acyclic
graphs using GOStats package in Bioconductor (Figure 3;
Figures S1 and S2). Terminal leaves of the graphs were
extracted for analysis. The complete list of packages used for GO
analysis is shown in the Methods S1 section.
DAVID Analysis
We used the Database for Annotation, Visualization, and
Integrated Discovery (DAVID) version 6.7 [75] to identify
annotation terms significantly enriched in each reference gene
set. We used the modified Fisher’s exact test, or EASE score, to
identify enriched annotation terms derived from GNF_U133A_
QUARTILE and gene ontology (GO) annotation terms, which
includes Biological Process (BP), Molecular function (MF), and
Cellular Component (CC) categories. We used the more specific
GO term categories provided by DAVID, called GO FAT, to
minimize the redundancy of the more general GO terms in the
analysis to increase the specificity of the terms.
A list of gene symbols was generated for each dataset and used as
input into DAVID. We used the Functional Annotation Tool, with
the Human Genome U133A Plus 2.0 Array as the gene background,
to independently analyze each gene set. We used a count threshold of
5 and the default value of 0.1 for the EASE score settings. We also
used the Benjamini corrected P-value, with p,0.05 as the
significance threshold. Significant annotation terms identified in the
GNF annotation category were further filtered using the interquartile
range of the category size, where the 1
st and 3
rd quartile were
removed from the results. Significant annotation terms in the
remaining GO annotation categories were filtered by removing those
terms with a category size less than 100 and greater than 1000.
Genome-Wide Expression Profile
We used the biomaRt package of Bioconductor to screen the
human genomic sequence at Ensembl database (NCBI build 36)
with the optimized AutRef84 profile. For this analysis, hgu133a
was used as the universe.
Network Visualization
To convey overlapping gene expression between these four
regions, we produced a bipartite network consisting of AutRef84
Figure 5. Genome-wide screening with the functional AutRef84
profile. The functional profile of AutRef84 was used to predict ASD
genes and map them to their appropriate location on the chromosome.
To perform this data mining, we used the biomaRT package of
Bioconductor from human genome at the Ensembl database (http://
www.ensembl.org/Homo_sapiens) to create a graphical representation
of chromosomal locations of genes matching with the functional
AutRef84 profile. The complete list of 1185 matching genes is provided
as Table S7. This map indicates uneven distribution with dense
packing of matched genes in discrete chromosomal regions, 13 of
which reached statistical significance (Table S8).
doi:10.1371/journal.pone.0028431.g005
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links between the genes and their corresponding brain regions. We
then assigned a category to each gene with respect to its linked
brain regions. (For example, genes expressed in the occipital lobe
and in the pituitary were placed in one category, while genes
expressed only in the prefrontal cortex were placed in another, and
so on.) Next, we used the attribute circle layout in Cytoscape [76]
to arrange the nodes in each category into circles. Each circle was
then manually repositioned in a location close to its linked brain
region or regions. The four brain region nodes were assigned
colors based on their positions in an RGB (red, green, blue) cube
color space [77]. The color of the nodes in each gene category
circle was derived by averaging R, G, and B values of the colors of
the linked brain region nodes.
Supporting Information
Figure S1 AutRef84 functional profile: graphical repre-
sentation of over-represented Molecular Function (MF)
categories. Using Bioconductor, we generated directed acyclic
graphs based on GO knowledge structure. Enriched GO
categories of AutRef84 are represented by rectangular boxes.
Terminal nodes are illustrated in yellow. Similar to the AutRef84
BP GO Tree (Figure 2), enriched terminal nodes also relate to ion
channel activity (voltage-gated cation channel activity: 6 genes,
P=7.0610
25; sodium ion binding: 5 genes, P=2.6610
24).
(PDF)
Figure S2 AutRef84 functional profile: graphical repre-
sentation of over-represented Cellular Component (CC)
categories. Using Bioconductor, we generated directed acyclic
graphs based on GO knowledge structure. Enriched GO
categories of AutRef84 are represented by rectangular boxes.
Terminal nodes are illustrated in yellow. Like the AutRef84 BP
GO Tree (Figure 2) and MF GO Tree (Figure S1), enriched
terminal nodes describe cellular components important for ion
channel activity (cation channel complex:6 genes, P=6.0610
25) or ion
channel activity/cell adhesion (synapse: 7 genes, P=6.2610
24).
(PDF)
Table S1 Expanded details of AutRef84 gene set.
(PDF)
Table S2 Enriched GO categories of AutRef84 using
DAVID analysis.
(PDF)
Table S3 KEGG pathway analysis of AutRef84 using
Onto Express.
(PDF)
Figure 6. Network representation of ASD predictive gene map matching the dual profile of AutRef84. After initially identifying 1185
genes matching the AutRef84 functional profile, we filtered this set by performing tissue-specific enrichment analysis and network representationo f
its shared brain regions within the AutRef84 expression profile. Using this method of dual profiling, we defined a prioritized subset of 460 genes
predicted to be mutated in individuals with ASD. Within this subset, 159 genes are expressed in all four enriched brain regions of AutRef84, 62 genes
were common to three of the enriched brain regions, 89 genes overlapped in two of the enriched regions, and 150 genes were expressed in only one
enriched brain region (Table S9). Node placement and coloring were determined as described in Figure 4.
doi:10.1371/journal.pone.0028431.g006
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enriched regions.
(PDF)
Table S5 Reference set of diabetes-linked genes.
(PDF)
Table S6 Non-specific disease gene set.
(PDF)
Table S7 Set of 1185 predicted ASD candidate genes
matching the AutRef84 functional profile.
(PDF)
Table S8 Significantly enriched cytoband categories for
the predictive set of 1185 genes using DAVID analysis.
(PDF)
Table S9 Set of 460 predicted ASD candidate genes
matching the AutRef84 dual profile.
(PDF)
Table S10 Previously identified ASD-linked genes
matching the AutRef84 dual profile which were not
included in the input dataset.
(PDF)
Methods S1 Bioconductor Statistics and Packages for
GO Enrichment Analysis.
(DOCX)
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